News
AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply ...
The global fish peptones market, valued at approximately USD 1,746.9 million in 2025, is projected to grow at a steady CAGR ...
EKF Diagnostics said in an update on Monday that it made good progress in the first half of 2025, with strong operational ...
M.M.R.V. vaccine: This combination vaccine for measles, mumps, rubella and chickenpox is on the agenda under “proposed recommendations” regarding its use in children younger than 4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results